Newsfeeds Archive - Spark Newswire

2 minute read

Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes For IkT-001Pro For Pulmonary Arterial Hypertension

May 9, 8:52 AM

- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension –BOSTON and ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Inhibikase

IKT

4 minute read

Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

April 22, 1:26 PM

Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday’s session after the company announced its intention to voluntarily…

AAOI

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

April 22, 12:31 PM

Gainers NKGen Biotech (NASDAQ:NKGN) shares rose 33.8% to $1.48 during Monday’s regular session. The company’s market cap stands…

BPTH

3 minute read

Inhibikase Therapeutics Issues Letter To Shareholders And Provides Update On Development Programs; Says 201 Trial Is ~75% Enrolled

By Benzinga Newsdesk

April 18, 4:37 PM

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"),

IKT

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

January 26, 1:31 PM

Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares moved upwards by 309.1% to $34.53 during Friday’s regular session. The market value…

ACON

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

January 25, 1:31 PM

Gainers Onconetix (NASDAQ:ONCO) stock rose 161.5% to $0.39 during Thursday’s regular session. The market value of their outstanding…

AFIB

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

January 24, 1:31 PM

Gainers Kura Oncology (NASDAQ:KURA) stock rose 48.1% to $19.87 during Wednesday’s regular session. The market value of their…

ANVS

3 minute read

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

January 5, 9:03 AM

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.

AIMD

3 minute read